Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125645851 | 12564585 | 1 | I | 20160704 | 20160718 | 20160718 | EXP | SE-AUROBINDO-AUR-APL-2016-09406 | AUROBINDO | 67.00 | YR | M | Y | 0.00000 | 20160718 | OT | SE | SE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125645851 | 12564585 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, UNK | U | U | 77095 | 500 | MG | FILM-COATED TABLET | |||||
| 125645851 | 12564585 | 2 | SS | LYXUMIA | LIXISENATIDE | 1 | Unknown | 20 MCG, UNK | U | U | 0 | INJECTION | |||||||
| 125645851 | 12564585 | 3 | SS | ENALAPRIL | ENALAPRIL | 1 | Oral | 5 MG, UNK | U | U | 0 | 5 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125645851 | 12564585 | 1 | Product used for unknown indication |
| 125645851 | 12564585 | 2 | Product used for unknown indication |
| 125645851 | 12564585 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125645851 | 12564585 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125645851 | 12564585 | Acute kidney injury | |
| 125645851 | 12564585 | Arrhythmia | |
| 125645851 | 12564585 | Lactic acidosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |